Felix Geringswald/iStock Editorial via Getty Images
- Abbott (NYSE:ABT) signs an agreement to integrate data from its glucose monitoring devices, the Libre CGM systems, directly into healthcare software firm Epic’s electronic health record in the U.S.
- This integration automatically links a user’s LibreView†data to Epic, letting clinicians access
